[{"Physician_Profile_ID": "802474", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "United Therapeutics Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010739", "Total_Amount_of_Payment_USDollars": "14950.00", "Date_of_Payment": "01/01/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "338551612", "Name_of_Associated_Covered_Drug_or_Biological1": "TYVASO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "STUDY OF INCIDENCE OF RESPIRATORY TRACT AES IN PATIENTS TREATED WITH TYVASO COMPARED TO OTHER FDA APPROVED PAH THERAPIES ASPIRE", "Research_Information_Link": "http://clinicaltrials.gov/ct2/show/NCT01266265", "Context_of_Research": "NA"}, {"Physician_Profile_ID": "802474", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "United Therapeutics Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010739", "Total_Amount_of_Payment_USDollars": "10125.00", "Date_of_Payment": "07/04/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "338551622", "Name_of_Associated_Covered_Drug_or_Biological1": "TYVASO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "STUDY OF INCIDENCE OF RESPIRATORY TRACT AES IN PATIENTS TREATED WITH TYVASO COMPARED TO OTHER FDA APPROVED PAH THERAPIES ASPIRE", "Research_Information_Link": "http://clinicaltrials.gov/ct2/show/NCT01266265", "Context_of_Research": "NA"}, {"Physician_Profile_ID": "802474", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "United Therapeutics Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010739", "Total_Amount_of_Payment_USDollars": "7500.00", "Date_of_Payment": "02/07/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "338551616", "Name_of_Associated_Covered_Drug_or_Biological1": "TYVASO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "STUDY OF INCIDENCE OF RESPIRATORY TRACT AES IN PATIENTS TREATED WITH TYVASO COMPARED TO OTHER FDA APPROVED PAH THERAPIES ASPIRE", "Research_Information_Link": "http://clinicaltrials.gov/ct2/show/NCT01266265", "Context_of_Research": "NA"}, {"Physician_Profile_ID": "802474", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "United Therapeutics Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010739", "Total_Amount_of_Payment_USDollars": "2875.00", "Date_of_Payment": "01/01/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "338551608", "Name_of_Associated_Covered_Drug_or_Biological1": "TYVASO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "STUDY OF INCIDENCE OF RESPIRATORY TRACT AES IN PATIENTS TREATED WITH TYVASO COMPARED TO OTHER FDA APPROVED PAH THERAPIES ASPIRE", "Research_Information_Link": "http://clinicaltrials.gov/ct2/show/NCT01266265", "Context_of_Research": "NA"}, {"Physician_Profile_ID": "802474", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "United Therapeutics Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010739", "Total_Amount_of_Payment_USDollars": "750.00", "Date_of_Payment": "03/10/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "338551618", "Name_of_Associated_Covered_Drug_or_Biological1": "TYVASO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "STUDY OF INCIDENCE OF RESPIRATORY TRACT AES IN PATIENTS TREATED WITH TYVASO COMPARED TO OTHER FDA APPROVED PAH THERAPIES ASPIRE", "Research_Information_Link": "http://clinicaltrials.gov/ct2/show/NCT01266265", "Context_of_Research": "NA"}]